Laurie A. Scheiner

Array ( [id] => 4376291 [patent_doc_number] => 06277383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Ryegrass pollen allergen' [patent_app_type] => 1 [patent_app_number] => 8/410614 [patent_app_country] => US [patent_app_date] => 1995-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 43 [patent_no_of_words] => 31355 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277383.pdf [firstpage_image] =>[orig_patent_app_number] => 410614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725732 [patent_doc_number] => 05670328 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/400530 [patent_app_country] => US [patent_app_date] => 1995-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8699 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670328.pdf [firstpage_image] =>[orig_patent_app_number] => 400530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7617176 [patent_doc_number] => 06946264 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-09-20 [patent_title] => 'Metalloproteinase inhibitor' [patent_app_type] => utility [patent_app_number] => 08/397320 [patent_app_country] => US [patent_app_date] => 1995-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 27 [patent_no_of_words] => 19735 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/946/06946264.pdf [firstpage_image] =>[orig_patent_app_number] => 08397320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950326 [patent_doc_number] => 05935580 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Recombinant mutants for inducing specific immune responses' [patent_app_type] => 1 [patent_app_number] => 8/395204 [patent_app_country] => US [patent_app_date] => 1995-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6019 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935580.pdf [firstpage_image] =>[orig_patent_app_number] => 395204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3847272 [patent_doc_number] => 05766867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Non-A, non-B hepatitis related nucleic acids, proteins, peptides, antigens, and antibodies' [patent_app_type] => 1 [patent_app_number] => 8/394326 [patent_app_country] => US [patent_app_date] => 1995-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 8819 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766867.pdf [firstpage_image] =>[orig_patent_app_number] => 394326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4241249 [patent_doc_number] => 06080840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Soluble T cell receptors' [patent_app_type] => 1 [patent_app_number] => 8/393157 [patent_app_country] => US [patent_app_date] => 1995-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 15 [patent_no_of_words] => 7883 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080840.pdf [firstpage_image] =>[orig_patent_app_number] => 393157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3460413 [patent_doc_number] => 05468634 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-21 [patent_title] => 'Axl oncogene' [patent_app_type] => 1 [patent_app_number] => 8/372892 [patent_app_country] => US [patent_app_date] => 1995-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10590 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/468/05468634.pdf [firstpage_image] =>[orig_patent_app_number] => 372892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098847 [patent_doc_number] => 06096879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Nucleotide sequence comprising the genome of hepatitis B virus, nucleotide sequence coding the surface antigen of the hepatitis B virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby' [patent_app_type] => 1 [patent_app_number] => 8/369998 [patent_app_country] => US [patent_app_date] => 1995-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 28 [patent_no_of_words] => 11010 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096879.pdf [firstpage_image] =>[orig_patent_app_number] => 369998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4376036 [patent_doc_number] => 06261571 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/364829 [patent_app_country] => US [patent_app_date] => 1994-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 13129 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261571.pdf [firstpage_image] =>[orig_patent_app_number] => 364829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3722333 [patent_doc_number] => 05681695 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Method for increasing specificity in competitive immunoassays' [patent_app_type] => 1 [patent_app_number] => 8/357369 [patent_app_country] => US [patent_app_date] => 1994-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 5476 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681695.pdf [firstpage_image] =>[orig_patent_app_number] => 357369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550018 [patent_doc_number] => 06399368 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Secretion of T cell receptor fragments from recombinant Escherichia coli cells' [patent_app_type] => B1 [patent_app_number] => 08/353940 [patent_app_country] => US [patent_app_date] => 1994-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 10886 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399368.pdf [firstpage_image] =>[orig_patent_app_number] => 08353940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3583082 [patent_doc_number] => 05552143 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Recombinant cytomegalovirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/349006 [patent_app_country] => US [patent_app_date] => 1994-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 11563 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552143.pdf [firstpage_image] =>[orig_patent_app_number] => 349006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4111171 [patent_doc_number] => 06057436 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Canine coronavirus S gene and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/331625 [patent_app_country] => US [patent_app_date] => 1994-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26746 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057436.pdf [firstpage_image] =>[orig_patent_app_number] => 331625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4423389 [patent_doc_number] => 06225458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Process for the production of DNA comprising the genome of the hepatitis B virus and vector including it' [patent_app_type] => 1 [patent_app_number] => 8/347162 [patent_app_country] => US [patent_app_date] => 1994-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 6 [patent_no_of_words] => 4237 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225458.pdf [firstpage_image] =>[orig_patent_app_number] => 347162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4233570 [patent_doc_number] => 06165745 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Recombinant production of immunoglobulin-like domains in prokaryotic cells' [patent_app_type] => 1 [patent_app_number] => 8/341560 [patent_app_country] => US [patent_app_date] => 1994-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 27634 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165745.pdf [firstpage_image] =>[orig_patent_app_number] => 341560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3513411 [patent_doc_number] => 05512460 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => 'Glia activating factor and its production' [patent_app_type] => 1 [patent_app_number] => 8/340820 [patent_app_country] => US [patent_app_date] => 1994-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 35 [patent_no_of_words] => 16597 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512460.pdf [firstpage_image] =>[orig_patent_app_number] => 340820 [rel_patent_id] =>[rel_patent_doc_number] =>)